30 August 2024 - The agenda for the September 2024 PBAC intracycle meeting is now available.

The PBAC will consider submissions for the following technologies:

• Fruquintinib (Fruzaqla) - new medicine
• Osilodrostat phosphate (Isturisa) - new medicine

Read PBS News